当前位置: X-MOL 学术Molecules › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of 99mTc-Labelled Methotrexate
Molecules ( IF 4.6 ) Pub Date : 2021-09-27 , DOI: 10.3390/molecules26195862
Przemysław Koźmiński 1 , Paweł Krzysztof Halik 1 , Raphael Chesori 1 , Ewa Gniazdowska 1
Affiliation  

The aim of the work carried out was to draw attention to shortcomings that often appear at the stage of designing new radiopharmaceuticals. Based on a case study of 99mTc-labelled methotrexate, this article describes frequent mistakes or misconceptions present not only in the referenced studies, but also in numerous radiopharmaceutical studies. The recommendations provided in this article highlight fundamental aspects of the credibility of radiopharmaceutical scientific research leading to the reliable results.

中文翻译:

放射性药物设计研究中的常见缺陷:以 99mTc 标记的甲氨蝶呤为例

开展的工作旨在引起人们对在设计新放射性药物阶段经常出现的缺点的关注。基于99m Tc 标记的甲氨蝶呤案例研究,本文描述了不仅在参考研究中而且在许多放射性药物研究中经常出现的错误或误解。本文中提供的建议突出了导致可靠结果的放射性药物科学研究可信度的基本方面。
更新日期:2021-09-27
down
wechat
bug